Prevalence of the most frequent BRCA1 mutations in Polish population

被引:39
作者
Brozek, Izabela [1 ]
Cybulska, Celina [1 ]
Ratajska, Magdalena [1 ]
Piatkowska, Magdalena [2 ,3 ]
Kluska, Anna [2 ,3 ]
Balabas, Aneta [2 ,3 ]
Dabrowska, Michalina [2 ,3 ]
Nowakowska, Dorota [2 ,3 ]
Niwinska, Anna [2 ,3 ]
Pamula-Pilat, Jolanta [4 ,5 ]
Tecza, Karolina [4 ,5 ]
Pekala, Wioletta [4 ,5 ]
Rembowska, Jolanta [6 ]
Nowicka, Karina [6 ]
Mosor, Maria [6 ]
Januszkiewicz-Lewandowska, Danuta [6 ]
Rachtan, Jadwiga [7 ]
Grzybowska, Ewa [4 ,5 ]
Nowak, Jerzy [6 ]
Steffen, Jan [2 ,3 ]
Limon, Janusz [1 ]
机构
[1] Med Univ Gdansk, Dept Biol & Genet, PL-80211 Gdansk, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Immunol, Warsaw, Poland
[3] Inst Oncol, Warsaw, Poland
[4] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Biol, Gliwice, Poland
[5] Inst Oncol, Gliwice, Poland
[6] Polish Acad Sci, Inst Human Genet, Dept Mol Pathol, PL-60479 Poznan, Poland
[7] Maria Sklodowska Curie Mem Inst Oncol, Epidemiol Unit, Ctr Oncol, Krakow, Poland
关键词
BRCA1; mutations; BRCA1 in Poland; Hereditary breast cancer; OVARIAN-CANCER FAMILIES; BREAST-CANCER; FOUNDER MUTATIONS; BREAST/OVARIAN CANCER; CARRIERS; RISK; GENE; HEREDITARY; WOMEN; 5382INSC;
D O I
10.1007/s13353-011-0040-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The purpose of our study was to establish the frequency and distribution of the four most common BRCA1 mutations in Polish general population and in a series of breast cancer patients. Analysis of the population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3819del5 (c.3700_3704del5) mutations of the BRCA1 gene were performed on a group of respectively 16,849, 13,462, 12,485 and 3923 anonymous samples collected at birth in seven Polish provinces. The patient group consisted of 1845 consecutive female breast cancer cases. The most frequent BRCA1 mutation in the general population was 5382insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respectively 11 of 13,462 (0.08%)and four of 3923 (0.1%) samples. The population prevalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer cases were, respectively, 1.9% (35/1845) and 1.2% (18/1486). Comparing these data with the population frequency, we calculated the relative risk of breast cancer for 5382insC mutation at OR = 17 and for 300T >G mutation at OR = 26. Our results, based on large population studies, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general population. Carriage of one of these mutations is connected with a very high relative risk of breast cancer.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 40 条
[1]   A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[2]   Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations:: a combined analysis of 22 population based studies [J].
Antoniou, AC ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (07) :602-603
[3]  
Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365
[4]   Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers [J].
Brozek, I. ;
Ochman, K. ;
Debniak, J. ;
Morzuch, L. ;
Ratajska, M. ;
Stepnowska, M. ;
Stukan, M. ;
Emerich, J. ;
Limon, J. .
JOURNAL OF APPLIED GENETICS, 2009, 50 (04) :379-384
[5]   High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland [J].
Brozek, Izabela ;
Ochman, Karolina ;
Debniak, Jaroslaw ;
Morzuch, Lucyna ;
Ratajska, Magdalena ;
Stepnowska, Magdalena ;
Stukan, Maciej ;
Emerich, Janusz ;
Limon, Janusz .
GYNECOLOGIC ONCOLOGY, 2008, 108 (02) :433-437
[6]  
Csokay B, 1999, Hum Mutat, V14, P92, DOI 10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU23>3.0.CO
[7]  
2-2
[8]   The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania [J].
Elsakov, P. ;
Kurtinaitis, J. ;
Petraitis, S. ;
Ostapenko, V. ;
Razumas, M. ;
Razumas, T. ;
Meskauskas, R. ;
Petrulis, K. ;
Luksite, A. ;
Lubinski, J. ;
Gorski, B. ;
Narod, S. A. ;
Gronwald, J. .
CLINICAL GENETICS, 2010, 78 (04) :373-376
[9]   Founder mutations in BRCA1 and BRCA2 genes [J].
Ferla, R. ;
Calo, V. ;
Cascio, S. ;
Rinaldi, G. ;
Badalamenti, G. ;
Carreca, I. ;
Surmacz, E. ;
Coliucci, G. ;
Bazan, V. ;
Russo, A. .
ANNALS OF ONCOLOGY, 2007, 18 :93-98
[10]   Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients [J].
Fodor, FH ;
Weston, A ;
Bleiweiss, IJ ;
McCurdy, LD ;
Walsh, MM ;
Tartter, PI ;
Brower, ST ;
Eng, CM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :45-51